Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Assets Average (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Assets Average of $6.2 billion for Q2 2026, down 1.93% on a QoQ basis from $6.3 billion in Q1 2026, and up 5.53% year-over-year from $5.9 billion in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Assets Average (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Assets Average for 17 years, with the latest figure at $6.2 billion in Q2 2026.

  • On a quarterly basis, Assets Average rose 5.53% year-over-year to $6.2 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 5.53% increase from a year earlier, with the FY2026 full-year figure at $6.0 billion, up 14.63% from the prior year.
  • Assets Average was $6.2 billion for Q2 2026 at Dr Reddys Laboratories, down from $6.3 billion in the prior quarter.
  • The five-year high for Assets Average was $6.3 billion in Q1 2026, with the low at $3.7 billion in Q4 2022.
  • Average Assets Average over 5 years is $4.9 billion, with a median of $4.7 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Assets Average fell 1.49% in 2022, then advanced 29.8% in 2024.
  • Over 5 years, Assets Average stood at $3.7 billion in 2022, then advanced by 16.97% to $4.3 billion in 2023, then rose by 29.8% to $5.6 billion in 2024, then increased by 11.32% to $6.3 billion in 2025, then retreated by 0.96% to $6.2 billion in 2026.
  • The last three Assets Average figures came in at $6.2 billion (Q2 2026), $6.3 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 39.95 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 35.94 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 6.21 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 3.66 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 24.65 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 1.50 Bn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 1.46 Bn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 1.70 Bn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 73.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 21.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.21 Bn
Mar 31, 2026 6.33 Bn
Dec 31, 2025 6.27 Bn
Sep 30, 2025 6.14 Bn
Jun 30, 2025 5.88 Bn
Mar 31, 2025 5.70 Bn
Dec 31, 2024 5.63 Bn
Sep 30, 2024 5.27 Bn
Jun 30, 2024 4.82 Bn
Mar 31, 2024 4.57 Bn
Dec 31, 2023 4.34 Bn
Sep 30, 2023 4.14 Bn
Jun 30, 2023 4.00 Bn
Mar 31, 2023 3.84 Bn
Dec 31, 2022 3.71 Bn
Sep 30, 2022 3.74 Bn
Jun 30, 2022 3.87 Bn
Mar 31, 2022 3.83 Bn
Dec 31, 2021 3.76 Bn
Sep 30, 2021 3.77 Bn